Clinical Trial Update: Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals [Phase 4]

View source ↗

Summary

Phase 4 trial comparing raltegravir to lopinavir/ritonavir, both with Truvada, in treatment-naive HIV-infected individuals; study terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)
• Raltegravir (raltegravir)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: George Washington University | Conditions: HIV Infections | Phase 4 | Status: TERMINATED | Results posted: 2017-06-26